Green Park & Golf Ventures
Venture capitalDallas · Pre-Seed–Growth · 10 people tracked
Investment thesis
Green Park & Golf Ventures pursues investment opportunities in medical-related startups that can deliver above-market returns. Building on the founders' operational track record from MedicalEdge and PhyServe, the firm seeks disruptive, fresh ideas addressing large markets with high barriers to entry, backed by passionate, seasoned management teams of two or more people. It values companies that treat others with compassion and dignity and that align incentives across owners, management and employees. Typical investments range from $500,000 to $2,000,000, deployed as either start-up or growth capital, with the firm's level of involvement varying based on the entrepreneur's needs and the company's stage.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website
What they invest in
from 25 of 59 portfolio companiesBiotech ×12Healthtech ×8Medical Devices ×6AI & Machine Learning ×5Digital Health ×4SaaS ×4Deep Tech ×3Enterprise Software ×3
HQs:United States×22
Investments · 59 tracked
founders shown can be your intro pathLantern Pharma develops AI and machine learning tools to identify which patients will respond to oncology drugs before clinical trials, reducing development costs and improving approval odds.
AI & Machine LearningBiotech
Donald Jeffrey Keyser(Chairman of the Board)David R. Margrave(Chief Financial Officer, Secretary)Panna Sharma(Chief Executive Officer, President)Kishor G. Bhatia(Chief Scientific Officer)Lee T. Schalop(Director)Vijay Chandru(Director)
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)Richard J. Hawkins(Director)An van Es-Johansson(Director)Ricky Sun(Director)Taneli Jouhikainen(Executive Officer)Mike Ciesla(Executive Officer)
Dallas, US
Lance M Hardenburg(Manager of the General Partner of Issuer)Carl D Soderstrom(Manager of the General Partner of Issuer)Jason L Signor(Manager of the General Partner of Issuer)
Board seatCarl Soderstrom· per SEC Form D · $4M raise · filed Jan 2018
Dallas, US
Carl D Soderstrom(Manager of the General Partner of Issuer)Lance M Hardenburg(Manager of the General Partner of Issuer)Jason L Signor(Manager of the General Partner of Issuer)
Board seatCarl Soderstrom· per SEC Form D · $3.1M raise · filed Oct 2017
Dallas, US
Carl D Soderstrom(Manager of the General Partner of Issuer)Jason L Signor(Manager of the General Partner of Issuer)Lance M Hardenburg(Manager of the General Partner of Issuer)
Board seatCarl Soderstrom· per SEC Form D · $3.4M raise · filed Jul 2017
Develops venous access devices made from patented biocompatible biomaterials designed to reduce infections, thrombosis, and phlebitis in intravenous therapy.
BiotechBedford, US
Paul Sabin(Director)Joseph Pellegrino(Director)James Biggins(Executive Officer, Director)Brent Ratz(Director)
Austin, US
JR Garcia(Director)Rina Hartline(Director)Mark S. Wochner(Executive Officer, Director)John Paulos(Director)
BiotechTarpon Springs, US
Oliver Schlueter(Executive Officer, Director)Christian Roesky(Director)Barry Butler(Executive Officer, Director)Christopher Jones(Director)Albert Rudick(Director)Haley Lemon(Executive Officer)
HealthtechBothell, US
Caitlin Morse(Executive Officer, Director, Promoter)Stephen Morse(Executive Officer, Director)
BoardAndrew Chomer(Director)
Cariloop provides digital and human-centered support services to relieve stress and anxiety experienced by family caregivers.
Enterprise SoftwareHealthtechHR TechImpact & Social GoodSaaSDallas, US
Michael Walsh(Co-Founder, Chief Executive Officer, and Board Chair)Steven Theesfeld(Executive Officer, Director)Michael Stoltz(Director)
HealthtechEmeryville, US
Dr. Jason Hong(Director)Daniel Burnett(Director)Anthony Natale(Director)Carter Mayer(Director)Ulric Cote(Executive Officer, Director)Andrew Farquharson(Director)
CounterFind is a SaaS platform that helps brands detect and remove online counterfeit listings and trademark or copyright infringements across e-commerce and social media.
CybersecurityLegalTechSaaSFrisco, US
Darren Woodson(Co-founder & Chairman)Michael DeCoursey(Executive Officer, Director)Robert Wechsler(Director)Jamie Gerson(Co-founder / Head of Strategic Partnerships & Infringement Recovery)Rachel Aronson(Co-founder / Head of Business Development & Marketing)Don Adam(CEO)
Earthview develops methane emissions monitoring technology through its BluBird product, combining custom-built hardware with in-house engineered software.
CleantechClimate TechDeep TechHardwareDallas, US
John Reed(Executive Officer, Director)Frederick Bear Givhan(Executive Officer, Director)Bear Givhan(Co-founder & CEO)Jim Maslanik(Co-founder & Chief Scientist)Kevin Yoon(VP of Product)
BiotechOmaha, US
Danial Burnett(Director)Carter Meyer(Director)Evan Luxon(Director)Deepak Gangahar(Director)Alan Chesler(Director)
Genomenon uses purpose-built AI combined with expert scientific curation to index and structure real-world evidence from millions of biomedical articles, including full text, tables, figures, and supplemental data.
AI & Machine LearningBiotechDigital HealthAnn Arbor, US
Eli Salembier(Executive Officer, Director)Mark Kiel(Executive Officer, Director)Sonya Sepahban(Director)Michael Klein(Executive Officer, Director)Patricia Glaza(Director)David Gregorka(Director)
BiotechHouston, US
Joseph Walowski(Director)Victoria Niklas(Director)Richard C. Jr. Cilento(Executive Officer, Director)Dan Watkins(Director)Frank Foster(Director)
Hypergiant develops AI-enabled software platforms that process data and deliver actionable intelligence for rapid decision-making, serving Fortune 500 companies and government agencies.
AI & Machine LearningData & InfrastructureDefense TechEnterprise SoftwareAustin, US
Ben Lamm
Iterion Therapeutics is a clinical-stage biopharmaceutical company developing Tegavivint, a targeted Wnt/β-catenin inhibitor for cancers with Wnt-driven mutations, primarily hepatocellular carcinoma and colorectal cancer.
BiotechMedical Devices
HealthtechTucson, US
David Specht(Executive Officer, Director)Robert Dench(Director)Stephen G Tolchin(Director)Donald F Specht(Director)Edward Miner(Director)Lothar Koob(Director)
Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment.
BiotechDeep TechDigital HealthMedical Devices
Noninvasix is developing a patented optoacoustic platform to non-invasively and continuously measure central venous oxygen saturation, an indicator of sepsis and septic shock severity.
Digital HealthHardwareMedical Devices
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams.
AI & Machine LearningBiotechHealthtechMedical Devices<UNKNOWN>, US
Tom Loftus(Director)Robert Epstein(Director)David West, Sr.(Executive Officer, Director)David West, Jr.(Executive Officer, Director)
BoardAlex Niehenke(Director)
Radformation develops software that automates and optimizes the radiation therapy treatment planning workflow, offering tools such as AutoContour, ClearCheck, and ChartCheck to standardize plans, reduce errors, and speed up patient treatment.
HealthtechMedical DevicesSaaSNew York, US
Kurt Sysock(Executive Officer, Director, Promoter)Kurt S(Co-Founder & CEO)Alan N(CTO, Co-founder)Liz V(Co-founder & CXO)Karl O(CSO)
Supergoop makes a line of SPF sunscreen products designed for different skin tones, activities, and occasions.
ConsumerWellness & Fitness
Worlds develops AI technology for processing and analyzing visual data in spatial and temporal context to enable enterprise applications in the physical world.
Advanced ManufacturingAI & Machine LearningDeep TechEnterprise Software
Dave Copps(CEO)Chris Rhode(President)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Green Park & Golf Ventures invest at?
- Green Park & Golf Ventures invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
- What is Green Park & Golf Ventures's typical check size?
- Green Park & Golf Ventures typically writes checks of $500K – $2M.
- What sectors does Green Park & Golf Ventures focus on?
- Green Park & Golf Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Green Park & Golf Ventures located?
- Green Park & Golf Ventures is headquartered in Dallas, US.
Co-investors · 1
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
Firms observed investing alongside Green Park & Golf Ventures, from public investor directories. Shared companies are the overlap with Green Park & Golf Ventures's recorded portfolio.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.